Natalia Sevillano

Title: **Inventor Spotlight: Natalia Sevillano**

Introduction

Natalia Sevillano, a prominent inventor based in San Francisco, CA, has made significant contributions to the field of biomedical research. With a total of three patents to her name, she has focused her innovative efforts on developing novel therapies for cancer treatment.

Latest Patents

Her most recent patents revolve around antibodies that are specific for urokinase-type plasminogen activator (uPA). These inventions provide methods for treating cancer by targeting the active form of uPA, specifically binding to it without cross-reacting with non-human forms. In various embodiments, the binding of these antibodies to uPA leads to the internalization of a complex involving the antibody, uPA, and the urokinase-type plasminogen activator receptor (uPAR). The patents also address anti-uPA antibody conjugates and pharmaceutical formulations that incorporate these innovative antibodies. Additionally, methods and kits related to the anti-uPA antibodies and their applications are disclosed.

Career Highlights

Natalia has worked with esteemed institutions such as the University of California and CytomX Therapeutics, Inc. Throughout her career, she has demonstrated a commitment to advancing cancer therapies through her research and inventions.

Collaborations

During her professional journey, Natalia has collaborated with notable individuals such as Aaron M. Lebeau and Daniel Robert Hostetter. Their shared expertise in various fields has helped bring her groundbreaking inventions to fruition.

Conclusion

In conclusion, Natalia Sevillano is a distinguished inventor whose work in antibody development for cancer treatment represents the forefront of biomedical innovation. Her patents not only advance scientific knowledge but also hold promise for future therapeutic applications in the fight against cancer.